310 related articles for article (PubMed ID: 23382571)
61. Renal function change after switching tenofovir disoproxil fumarate for tenofovir alafenamide in the HIV-positive patients of a metropolitan sexual health service.
Turner D; Drak D; O'Connor CC; Templeton DJ; Gracey DM
AIDS Res Ther; 2019 Dec; 16(1):40. PubMed ID: 31810490
[TBL] [Abstract][Full Text] [Related]
62. Assessing renal impairment in treatment-naïve adolescents living with HIV commencing antiretroviral therapy in Zimbabwe.
Byers BW; Drak D; Shamu T; Chimbetete C; Dahwa R; Gracey DM
AIDS; 2023 Apr; 37(5):789-794. PubMed ID: 36728249
[TBL] [Abstract][Full Text] [Related]
63. Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.
Achhra AC; Nugent M; Mocroft A; Ryom L; Wyatt CM
Curr HIV/AIDS Rep; 2016 Jun; 13(3):149-57. PubMed ID: 27130284
[TBL] [Abstract][Full Text] [Related]
64. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons.
Mocroft A; Ryom L; Oprea C; Li Q; Rauch A; Boesecke C; Uzdaviniene V; Sedlacek D; Llibre JM; Lacombe K; Nielsen LN; Florence E; Aho I; Chkhartishvili N; Szlavik J; Dragovic G; Leen C; Sambatakou H; Staub T; Laguno M; Elinav H; Tomažič J; Peters L;
AIDS; 2020 Aug; 34(10):1485-1495. PubMed ID: 32675562
[TBL] [Abstract][Full Text] [Related]
65. Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa.
Onoya D; Hirasen K; van den Berg L; Miot J; Long LC; Fox MP
Drug Saf; 2018 Dec; 41(12):1343-1353. PubMed ID: 30043384
[TBL] [Abstract][Full Text] [Related]
66. Determinants of Risk Factors for Renal Impairment among HIV-Infected Patients Treated with Tenofovir Disoproxil Fumarate-Based Antiretroviral Regimen in Southern Vietnam.
Hoang CQ; Nguyen HD; Vu HQ; Nguyen KT; Hoang LT; Ly H; Tat TD; Phan LT
Biomed Res Int; 2020; 2020():7650104. PubMed ID: 32382572
[TBL] [Abstract][Full Text] [Related]
67. Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort.
Álvarez-Ossorio MJ; Sarmento E Castro R; Granados R; Macías J; Morano-Amado LE; Ríos MJ; Merino D; Álvarez EN; Collado A; Pérez-Pérez M; Téllez F; Martín JM; Méndez J; Pineda JA; Neukam K;
J Viral Hepat; 2018 Jun; 25(6):699-706. PubMed ID: 29377515
[TBL] [Abstract][Full Text] [Related]
68. HIV therapies and the kidney: some good, some not so good?
Ryom L; Mocroft A; Lundgren J
Curr HIV/AIDS Rep; 2012 Jun; 9(2):111-20. PubMed ID: 22370968
[TBL] [Abstract][Full Text] [Related]
69. Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy.
Bandera A; Gori A; Sabbatini F; Madeddu G; Bonora S; Libertone R; Mastroianni C; Bonfanti P; d'Arminio Monforte A; Cozzi-Lepri A;
PLoS One; 2015; 10(5):e0124252. PubMed ID: 25933346
[TBL] [Abstract][Full Text] [Related]
70. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.
Reid A; Stöhr W; Walker AS; Williams IG; Kityo C; Hughes P; Kambugu A; Gilks CF; Mugyenyi P; Munderi P; Hakim J; Gibb DM;
Clin Infect Dis; 2008 Apr; 46(8):1271-81. PubMed ID: 18444867
[TBL] [Abstract][Full Text] [Related]
71. Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study.
Prosperi MC; Fabbiani M; Fanti I; Zaccarelli M; Colafigli M; Mondi A; D'Avino A; Borghetti A; Cauda R; Di Giambenedetto S
BMC Infect Dis; 2012 Nov; 12():296. PubMed ID: 23145925
[TBL] [Abstract][Full Text] [Related]
72. Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir.
Yilma D; Abdissa A; Kæstel P; Tesfaye M; Olsen MF; Girma T; Ritz C; Friis H; Andersen ÅB; Kirk O
BMC Infect Dis; 2020 Aug; 20(1):582. PubMed ID: 32762646
[TBL] [Abstract][Full Text] [Related]
73. Comparative analysis of the new chronic kidney disease epidemiology collaboration and the modification of diet in renal disease equations for estimation of glomerular filtration rate in HIV type 1-infected subjects.
Dabrowska MM; Mikula T; Stanczak W; Malyszko J; Wiercinska-Drapalo A
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):809-13. PubMed ID: 21284524
[TBL] [Abstract][Full Text] [Related]
74. Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
Hatleberg CI; Ryom L; d'Arminio Monforte A; Fontas E; Reiss P; Kirk O; El-Sadr W; Phillips A; de Wit S; Dabis F; Weber R; Law M; Lundgren JD; Sabin C;
HIV Med; 2018 Oct; 19(9):605-618. PubMed ID: 30019813
[TBL] [Abstract][Full Text] [Related]
75. Ritonavir-boosted paritaprevir, ombitasvir plus ribavirin could improve eGFR in patients with renal impairment and HCV: an Egyptian cohort.
Said M; Omar H; Soliman Z; Saad Y; Dabes H; Hamed S; ElSaeed K; ElShazly Y; ElSerafy M
Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):89-93. PubMed ID: 30791838
[TBL] [Abstract][Full Text] [Related]
76. Kidney Dysfunction and the Risk of Developing Aortic Stenosis.
Vavilis G; Bäck M; Occhino G; Trevisan M; Bellocco R; Evans M; Lindholm B; Szummer K; Carrero JJ
J Am Coll Cardiol; 2019 Jan; 73(3):305-314. PubMed ID: 30678761
[TBL] [Abstract][Full Text] [Related]
77. Tenofovir-associated renal toxicity in a cohort of HIV infected patients in Ghana.
Nartey ET; Tetteh RA; Yankey BA; Mantel-Teeuwisse AK; Leufkens HGM; Dodoo ANO; Lartey M
BMC Res Notes; 2019 Jul; 12(1):445. PubMed ID: 31331365
[TBL] [Abstract][Full Text] [Related]
78. Impact of antiretroviral therapy on renal function among HIV-infected Tanzanian adults: a retrospective cohort study.
Mpondo BC; Kalluvya SE; Peck RN; Kabangila R; Kidenya BR; Ephraim L; Fitzgerald DW; Downs JA
PLoS One; 2014; 9(2):e89573. PubMed ID: 24586882
[TBL] [Abstract][Full Text] [Related]
79. Predictors of renal impairment and proteinuria after commencement of antiretroviral therapy in a Zimbabwean HIV cohort.
Drak D; Heron JE; Shamu T; Chimbetete C; Dahwa R; Gracey DM
HIV Med; 2022 Oct; 23(9):1002-1006. PubMed ID: 35394105
[TBL] [Abstract][Full Text] [Related]
80. Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review.
Bagnis CI; Stellbrink HJ
Infect Dis Ther; 2015 Jan; 4(1):15-50. PubMed ID: 25567681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
